Edward Henry Reynolds

Edward Henry Reynolds's AcademicInfluence.com Rankings

Biology

#7912

World Rank

#10905

Historical Rank

Genetics

#772

World Rank

#864

Historical Rank

Molecular Biology

#955

World Rank

#978

Historical Rank

Neuroscience

#1061

World Rank

#1103

Historical Rank

biology Degrees

Download Badge

Biology

Edward Henry Reynolds's Degrees

PhD Biochemistry University of Oxford
Bachelors Chemistry University of Oxford

Why Is Edward Henry Reynolds Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Edward Henry Reynolds's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Homocysteine, folate, methylation, and monoamine metabolism in depression (2000) (555)
Enhancement of recovery from psychiatric illness by methylfolate (1990) (324)
Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. (1990) (263)
The prognosis for seizure control in newly diagnosed epilepsy. (1984) (260)
Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. (1995) (248)
Monotherapy or Poly therapy for Epilepsy? (1981) (230)
The neuropsychiatry of megaloblastic anaemia. (1980) (219)
Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. (1977) (214)
Folic acid, ageing, depression, and dementia (2002) (214)
Folate deficiency in depressive illness. (1970) (182)
ONE DRUG FOR EPILEPSY (1978) (163)
METHYLATION AND MOOD (1984) (159)
Effects of folic acid on the mental state and fit-frequency of drug-treated epileptic patients. (1967) (158)
Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics. (1976) (157)
Red cell folate concentrations in psychiatric patients. (1990) (145)
Folic Acid in Neurology, Psychiatry and Internal Medicine (1979) (142)
WHY DOES EPILEPSY BECOME INTRACTABLE? Prevention of Chronic Epilepsy (1983) (138)
Anticonvulsant drugs and mental symptoms: a review (1976) (131)
Folate deficiency, biopterin and monoamine metabolism in depression (1992) (129)
The ILAE/IBE/WHO Global Campaign against Epilepsy: Bringing Epilepsy “Out of the Shadows” (2000) (124)
ONE DRUG (PHENYTOIN) IN THE TREATMENT OF EPILEPSY (1976) (121)
Mental effects of anticonvulsants, and folic acid metabolism. (1968) (117)
ONE DRUG (PHENYTOIN) IN TREATMENT OF EPILEPSY (1976) (115)
Benefits and risks of folic acid to the nervous system (2002) (115)
Enhancement of recovery from psychiatric illness by methylfolate (1992) (113)
PROGNOSIS AFTER A FIRST UNTREATED TONIC-CLONIC SEIZURE (1985) (101)
Serum Anticonvulsant Concentrations in Epileptic Patients with Mental Symptoms (1974) (100)
S-ADENOSYLMETHIONINE INFLUENCES MONOAMINE METABOLISM (1984) (86)
ANTICONVULSANT THERAPY, MEGALOBLASTIC HAEMOPOIESIS AND FOLIC ACID METABOLISM (1966) (84)
Drug treatment of epilepsy (1994) (84)
MANIPULATION OF BRAIN SEROTONIN IN THE TREATMENT OF MYOCLONUS (1975) (83)
Anticonvulsants, folic acid, and epilepsy. (1973) (82)
Folate therapy in epilepsy. A controlled study. (1973) (79)
MULTIPLE SCLEROSIS AND MACROCYTOSIS (1989) (79)
Folate status in a geriatric population and its relation to dementia. (1973) (78)
SWITCH MECHANISM IN AFFECTIVE ILLNESS AND S-ADENOSYLMETHIONINE (1983) (77)
The neurology of folic acid deficiency. (2014) (76)
Folic acid, S-adenosylmethionine and affective disorder (1983) (76)
Neurological Disease associated with Folate Deficiency (1973) (75)
The early treatment and prognosis of epilepsy. (1987) (75)
The course of untreated epilepsy. (1988) (74)
Predictive Value of Interictal Epileptiform Discharges During Non‐REM Sleep on Scalp EEG Recordings for the Lateralization of Epileptogenesis (1998) (71)
Schizophrenia-like Psychoses of Epilepsy and Disturbances of Folate and Vitamin B12 Metabolism Induced by Anticonvulsant Drugs (1967) (70)
DRUG TREATMENT OF EPILEPSY (1978) (69)
AMINES, ANTICONVULSANTS, AND EPILEPSY (1975) (67)
The Clinical Potential of Ademetionine (S-Adenosylmethionine) in Neurological Disorders (1994) (63)
Papilloedema and the Landry-Guillain-Barré syndrome. Case reports and a review. (1966) (61)
The distribution of plasma phenytoin levels in epileptic patients (1970) (61)
FIRST SEIZURE IN ADULT LIFE (1988) (60)
Multiple sclerosis and vitamin B12 metabolism (1992) (56)
PAPILLæDEMA AND THE LANDRY-GUILLAIN-BARRÉ SYNDROME (1966) (56)
Folate metabolism in epileptic and psychiatric patients (1971) (56)
Neurological aspects of folate and vitamin B12 metabolism. (1976) (54)
The Switch Mechanism and the Bipolar/Unipolar Dichotomy (1989) (53)
Clonazepam induces decreased serotoninergic activity in the mouse brain (1979) (51)
AMINES, ANTICONVULSANTS, AND EPILEPSY (1975) (50)
Reversible absorptive defects in anticonvulsant megaloblastic anaemia (1965) (50)
Subacute combined system degeneration with folate deficiency. (1972) (49)
Switch Mechanism in Affective Illness and Oral S-Adenosylmethionine (SAM) (1987) (48)
Water intoxication due to carbamazepine. (1977) (48)
Epilepsy, Behaviour and Cognitive Function (1990) (42)
Serum immunoglobulins in epilepsy. (1974) (42)
Folate in CSF and age (2000) (42)
Epilepsy and schizophrenia: relationship and biochemistry. (1968) (42)
S-adenosylmethionine and affective disorder. (1987) (38)
Folates and psychiatric disorders. Clinical potential. (1993) (38)
Folic acid and anticonvulsants. (1969) (36)
The influence of carbamazepine and phenytoin on memory and other aspects of cognitive function in new referrals with epilepsy (1984) (36)
Serum levels of anticonvulsant drugs. Interpretation and clinical value. (1980) (35)
Neuropsychiatric aspects of anticonvulsant megaloblastic anaemia. (1968) (34)
A brief history of hysteria: From the ancient to the modern. (2016) (34)
Introduction: Epilepsy in the World (2002) (33)
Lamotrigine for generalised epilepsies (1992) (33)
Plasma uric acid in patients receiving anticonvulsant monotherapy (1991) (32)
VITAMIN B12 DEFICIENCY, DEMYELINATION, AND MULTIPLE SCLEROSIS (1987) (31)
L-5-HYDROXYTRYPTOPHAN AND MOOD (1975) (31)
THE NEUROLOGY OF VITAMIN B12 DEFICIENCY Metabolic Mechanisms (1976) (31)
Interaction of phenytoin and primidone. (1975) (30)
Transmethylation in depression. (1988) (28)
Role of Vitamin B12 in Folate Coenzyme Synthesis (1976) (28)
Todd, Faraday, and the electrical basis of brain activity (2004) (27)
Cerebrotendinous xanthomatosis: biochemical response to inhibition of cholesterol synthesis. (1983) (27)
What is the safe upper intake level of folic acid for the nervous system? Implications for folic acid fortification policies (2016) (27)
Stroke in Babylonia. (2004) (25)
A Century of Achievements (2011) (25)
What Is Epilepsy: The Clinical and Scientific Basis of Epilepsy (1987) (25)
Myopathy associated with anticonvulsant osteomalacia. (1973) (25)
Interictal behaviour in temporal lobe epilepsy. (1983) (23)
The Pharmacological Management of Epilepsy Associated with Psychological Disorders (1982) (23)
The clinical concept of epilepsy (2009) (22)
The influence of S-adenosylmethionine (SAM) on prolactin in depressed patients. (1987) (22)
The effect of diphenylhydantoin on central catecholamine containing neuronal systems (1977) (22)
Chronic toxicity in epileptic patients receiving single-drug treatment (1982) (22)
The Influence of Seizure Type and Medication on Psychiatric Symptoms in Epileptic Patients (1986) (21)
Folate and monoamine metabolism in epilepsy (1975) (21)
When do epileptic patients need treatment? Starting and stopping medication. (1985) (21)
Hysteria, conversion and functional disorders: a neurological contribution to classification issues (2012) (20)
RELIEF OF ACTION MYOCLONUS BY 5-HYDROXYTRYPTOPHAN (1974) (20)
WITHDRAWAL OF ANTICOAGULANTS FROM PATIENTS WITH TRANSIENT ISCHAEMIC CEREBROVASCULAR ATTACKS. (1965) (19)
Letter: Amines, anticonvulsants, and epilepsy. (1975) (19)
Neurology and psychiatry in Babylon. (2014) (19)
Jackson, Todd, and the Concept of “Discharge” in Epilepsy (2007) (18)
Folates and Psychiatric Disorders (1993) (18)
Prediction of Outcome in Depressive Illness by the Newcastle Diagnosis Scale (1987) (17)
Iatrogenic disorders in epilepsy. (1970) (16)
Todd, Faraday, and the Electrical Basis of Epilepsy (2004) (16)
Gamma-vinyl GABA (vigabatrin): clinical experience in adult and adolescent patients with intractable epilepsy. (1992) (14)
Transport of 5-methyltetrahydrofolic acid into the cerebrospinal fluid in man. (1974) (14)
Effects of folic acid (2002) (14)
A Biochemical Study of Depressed Patients Receiving S-Adenosyl-L-Methionine (SAM) (1986) (13)
Adverse Neuropsychiatric Effects of Anticonvulsant Drugs (1985) (13)
Milestones in epilepsy * (2009) (13)
The John Hughlings Jackson 1935 Centenary Congress Medal (2005) (13)
Valproate and folate: Congenital and developmental risks (2020) (13)
Cerebrospinal-fluid folate and acid monoamine metabolites. (1972) (12)
CSF S-adenosylmethionine in neuropsychiatric disorders (1991) (12)
On stroke and facial palsy in babylonian texts (2007) (12)
Interictal psychiatric disorders. Neurochemical aspects. (1991) (12)
Depression and anxiety in Babylon (2013) (11)
The neurology of vitamin B12 deficiency (1979) (11)
Treating refractory epilepsy in adults (2006) (10)
Neurotoxicity of carbamazepine. (1975) (10)
Paediatric Perspectives on Epilepsy (1986) (10)
Vitamin B12 and Folate Deficiencies (1967) (9)
Folate and Neurological Disease: Basic Mechanisms (2009) (9)
Iatrogenic nutritional effects of anticonvulsants (1974) (9)
Anticonvulsants and mental symptoms. (2009) (9)
Switch and S-adenosylmethionine. (1988) (9)
A single seizure. (1988) (8)
Robert Bentley Todd's Contribution to Cell Theory and The Neuron Doctrine (2011) (8)
Anticonvulsant drugs, folic acid metabolism, fit frequency and psychiatric illness. (1971) (8)
Valproate versus carbamazepine for seizures. (1993) (8)
Obsessive compulsive disorder and psychopathic behaviour in Babylon (2011) (8)
Sudden death in the shadows of epilepsy (2003) (8)
Folate, Homocysteine and Monoamine Metabolism in Depression (1991) (8)
Folate has potential to cause harm (1995) (8)
Ascorbic acid concentrations in human plasma and cerebrospinal fluid [proceedings]. (1976) (7)
EXAGGERATED RESPONSE TO PARATHYROID EXTRACT IN SARCOIDOSIS. (1963) (7)
Kinnier Wilson on hysteria: a missing chapter? (2012) (7)
The risks of folic acid to the nervous system in vitamin B12 deficiency: rediscovered in the era of folic acid fortification policies (2017) (7)
Gastrointestinal function in anticonvulsant megaloblastic anaemia. (1966) (7)
FOLATE-RESPONSIVE SCHIZOPHRENIA (1975) (6)
Lamotrigine versus carbamazepine in epilepsy. (1995) (6)
ONE DRUG FOR EPILEPSY - REPLY (1978) (6)
Multiple sclerosis and vitamin B12 metabolism. (1992) (6)
Enhancement of recovery from psychiatric illness by methylfolate (1990) (6)
The historical evolution and future of neurology and psychiatry (2015) (6)
Lamotrigine versus carbamazepine in epilepsy (1995) (6)
Health insurance for doctors (1993) (6)
Todd, Faraday and the electrical basis of brain activity (2007) (6)
Variation in response to anticonvulsants in a group of epileptic patients. (1972) (6)
Tribulations for clinical trials (1991) (5)
Yorkshire’s influence on the understanding and treatment of mental diseases in Victorian Britain: The golden triad of York, Wakefield, and Leeds (2018) (5)
Unsatisfactory aspects of the drug treatment of epilepsy. (1976) (5)
CLOBAZAM FOR EPILEPSY (1988) (5)
Methylfolate as adjunctive treatment in major depression. (2013) (5)
Kinnier Wilson and Sherrington (2008) (5)
Longitudinal Studies of Serum Anti-Epileptic Drug Levels Preliminary Observations: Interaction of Phenytoin and Primidone (1975) (5)
VITAMIN-B12 DEFICIENCY IN PSYCHIATRY (1966) (5)
Folate metabolism and anticonvulsant therapy. (1974) (5)
Proceedings: Clonazepam-induced changes in 5-hydroxytryptamine (5-HT) metabolism in aminals and man. (1975) (4)
There is more to treatment of epilepsy than control of seizures (2005) (4)
PATHOGENESIS OF SUBACUTE COMBINED DEGENERATION (1981) (4)
Services for epilepsy in the United Kingdom (1997) (4)
Altered serotoninergic activity in mouse brain induced by clonazepam [proceedings]. (1978) (4)
A bridge between neurology and psychiatry (2016) (4)
Hughlings Jackson’s early education (2006) (3)
Antiepileptic drugs, folate and one carbon metabolism revisited (2020) (3)
Kinnier Wilson's French connections. (2015) (3)
Robert Bentley Todd's Electrical Theory of Epilepsy (2005) (3)
Epilepsy and Neuroscience: Evolution and Interaction (2020) (3)
Anglo-French neurological interactions in the 19th and early 20th centuries: Physicians, places and events. (2021) (3)
The influence of antiepileptic drugs on the natural history of epilepsy. (1991) (3)
A better future for the NHS: a historical perspective from the frontline (2018) (3)
Methylfolate as Monotherapy in Depression . A Pilot Randomised Controlled Trial (2015) (3)
Letter to the Editor and Authors' Response: Reaction to Abi-Rached JM (2012): From Brain to Neuro: The Brain Research Association and the Making of British Neuroscience, 1965–1996. Journal of the History of the Neurosciences 21:189–213) (2013) (3)
Vis attractiva and vis nervosa (2005) (3)
The origins of the British Neuroscience Association (2017) (2)
The Brainstorms Village: Epilepsy in our World (2004) (2)
Anticonvulsant drugs, folate deficiency, and metabolic bone disease. (1972) (2)
The Institute of Epileptology of King's College, University of London (1995) (2)
Effect of anticonvulsants on the uptake of 5-methyltetrahydrofolic acid by the choroid plexus in rabbits. (1977) (2)
Introduction to Epilepsy: Monotherapy or polytherapy? (2012) (2)
Folate and vitamin B12 in epilepsy. (1970) (2)
γ-vinyl GABA (Vigabatrin) : clinical experience in adult and adolescent patients with intractable epilepsy. Discussion (1992) (2)
Allbutt of Leeds and Duchenne de Boulogne: Newly discovered insights on Duchenne by a British neuropsychiatrist. (2018) (2)
Scientific meeting for launch of the Institute of Epileptology King's College, University of London, November 15, 1994, London (1995) (1)
Another opportunity to improve epilepsy services should not be lost (1987) (1)
Phenobarbital for epilepsy: much is still to be learnt (2005) (1)
Personalised medicine and National Health Service culture (2013) (1)
The earliest experimental convulsions by Joseph Priestley in 1766 friendship with Benjamin Franklin (2019) (1)
Hysteria in ancient civilisations: A neurological review Possible significance for the modern disorder (2018) (1)
Charting the ‘see’ David H Hubel Torsten N Wiesel (2005) (1)
Folate and ageing (2007) (1)
Internuclear ophthalmoplegia in pernicious anemia. (1989) (1)
SURGERY FOR TEMPORAL LOBE EPILEPSY (1989) (1)
MILESTONES IN THE HISTORY OF EPILEPSY 1 Introduction Epilepsy (2005) (1)
How do anticonvulsants work? (1978) (1)
Lamotrigine versus carbamazepine in epilepsy. (1995) (1)
Tribulin output in neurological disorders. (1987) (1)
Folate Status in Psychiatric Patients: Relationship with CSF Neurotransmitter Metabolites (1986) (1)
Editorial Commentary ILAE President's Mid‐Term Report (1996) (1)
How to avoid harmful national quarantines: primary care led local public health: a historical perspective (2021) (1)
Introduction to Epilepsy: History of epilepsy (2012) (1)
Neurometabolic approach to treatment-resistant depression (2019) (1)
The prevention of the importation of infectious diseases in England in 1877 (2020) (1)
Letter: L 5-Hydroxytryptophan and mood. (1975) (1)
Grey Matter John Hughlings Jackson and Thomas Laycock: brain and mind. (2019) (1)
Antiepileptic drugs and folate revisited. (2020) (1)
Robert Bentley Todd (1809–1860) (2005) (1)
British Neuropsychiatry Association (1990) (1)
International League Against Epilepsy – commissions , task forces and the Global Campaign Against Epilepsy (2009) (1)
Focus on Africa (1994) (1)
HÆMATOLOGICAL EFFECTS OF ANTICONVULSANT TREATMENT (1978) (1)
Clinical application of the monitoring of anticonvulsant drug levels. (1979) (1)
Maurice Parsonage (2009) (0)
Differential diagnosis of dementia (1986) (0)
Foreword (1995) (0)
The Problem of Delayed Justice (2012) (0)
The London Contribution to Neurology and Psychiatry: The second British Symposium on the History of Neurology and Psychiatry (2017) (0)
President's Address before the American Gynecological Society (1904) (0)
Modulation of picrotoxin-induced forepaw myoclonus in the rat by benzodiazepines [proceedings]. (1979) (0)
TRIBULATIONS FOR CLINICAL TRIALS. AUTHOR'S REPLY (1991) (0)
More on childhood clustering. (1994) (0)
One drug for epilepsy (1978) (0)
Mock Board Examination (2007) (0)
Robert Bentley Todd’s contributions to the structure and function of nerve tissue (2017) (0)
Compliance and epilepsy. (1980) (0)
Antipsychotic polypharmacy: lessons from antiepileptic polypharmacy (2011) (0)
The quality of information (2017) (0)
Bombing mental hospitals (1984) (0)
VALPROATE OR INFECTIVE HEPATITIS? (1986) (0)
Epilepsy symposium. Basic concepts and diagnosis. (1978) (0)
In Memoriam (1987) (0)
Behavioral Neurology (2nd Edition). By Jonathan H. Pincus and Gary J. Tucker. Oxford University Press. 1978. Pp 276. £5.95. (1979) (0)
Gavin Philip Henry (2011) (0)
Mandatory food fortification with folic acid. (2022) (0)
The earliest observations on facial palsy (2017) (0)
One drug for epilepsy [proceedings]. (1979) (0)
Vigabatrin. (1990) (0)
Media Watch Epilepsy and Movement Disorders Guerrini R (2002) (0)
Migraine and Other Headaches. (New trends in Clinical Neurology series) Edited by M. D. Ferrari and X. Lataste Caraforth: The Parthenon Publishing Group. 1989. 300 pp. £35.00. (1991) (0)
Introduction to Epilepsy: The International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) (2012) (0)
The women of SGIM (1995) (0)
EVALUATION AND TREATMENT OF SEIZURES. AUTHORS' REPLIES (1991) (0)
Epilepsy, behaviour, and cognitive function : Stratford-upon-Avon symposium, November 1987 (1988) (0)
The Ventricle of Memory . By M. Critchley. (Pp. 213; illustrated.) Raven Press: New York. 1990. (1994) (0)
Letter to the Editor and Authors' Response: Reaction to Abi-Rached JM (2012): From Brain to Neuro: The Brain Research Association and the Making of British Neuroscience, 1965–1996. Journal of the History of the Neurosciences 21:189–213 (2013) (0)
ANTICONVULSANT DRUGS AND PSYCHOPATHOLOGY (1984) (0)
Letter: Plasma levels of antidepressants and anticonvulsants. (1975) (0)
Points from letters: Hazards of psycho-active drugs (1975) (0)
Mental and physical illness (2001) (0)
Behavioral Neurology: A Practical Approach. By Howard S. Kirshner, Edinburgh: Churchill Livingstone. 1986. Pp 230. £24.50. (1987) (0)
Letter: Folate-responsive schizophrenia. (1975) (0)
When to Stop Antiepileptic Drugs (2020) (0)
Compliance or unnecessary prescribing? (1980) (0)
The effects of ethanol and anticonvulsants on erythroid delta-aminolaevulinic acid synthase. (1985) (0)
STRESS, DISTRESS, AND PSYCHOTROPIC DRUGS (1979) (0)
Letter: Folate-responsive neuropathy. (1976) (0)
In memoriam: Harry Meinardi (February 20, 1932-December 20, 2013). (2014) (0)
Introduction to Epilepsy: Foreword (2012) (0)
[A commemoration of British-French neurological connections during the years 1860-1920]. (2020) (0)
INDIFFERENCE TO EPILEPSY (1987) (0)
Affective ‘switch mechanisms’ (1989) (0)
Pathology of Anticonvulsant Therapy (1974) (0)
FOLIC ACID, VITAMIN B12 AND NEUROPSYCHIATRY (1984) (0)
Folate metabolism inepileptic andpsychiatric patients (1971) (0)
A Comparative Monotherapy Trial in Childhood Epilepsy (1989) (0)
Announcements (2011) (0)
Predictions of Outcome in Depressive Illness (1987) (0)
A Comparative Monotherapy Trial in Childhood Epilepsy (1989) (0)
Abnormal cobalamin metabolism in a case of juvenile pernicious anaemia with neurological symptoms (1981) (0)
Letter: Relief of action myoclonus by 5-hydroxytryptophan. (1974) (0)
Book Review (2008) (0)
The effects of ethanol and anticonvulsants on erythroid δ‐aminolaevulinic acid synthase (2009) (0)
Book Review (1990) (0)
A Message from the President of the International League Against Epilepsia (1994) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Edward Henry Reynolds?

Edward Henry Reynolds is affiliated with the following schools:

King's College, Aberdeen

Edward Henry Reynolds's Academic­Influence.com Rankings

Edward Henry Reynolds's Degrees

Why Is Edward Henry Reynolds Influential?

Edward Henry Reynolds's Published Works

Published Works

What Schools Are Affiliated With Edward Henry Reynolds?

Edward Henry Reynolds's AcademicInfluence.com Rankings